Public Title Casimiroin-Based Aromatase and QR2 Inhibitors Division Lead Inventor Public Description This invention consistes of a series of potent aromatase inhibitors with potential for the prevention and treatment of breast cancer and Cushing's syndrome. The potencies of the most active compounds in this series vs. aromatase are comparable to that of aminoglutethimine (Cytadren). Patent Status Public References Key Words Manager Matt McFarland Email mjmcfarland@prf.org Telephone 765-588-3487 Fax 765-463-3486   Back to List